Skip to Main Content

Paper Details

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.
Neurology
28
2018
CFH, CFHR4, Class I and II human leukocyte antigen, Class I and II human leukocyte antigen (HLA) alleles, HLA, HLA-A*31:01, MPE, carbamazepine, carbamazepine hypersensitivity, complement factor H, complement factor H (CFH) gene, complement factor H-related 4, complement factor H-related 4 (CFHR4) gene, complement factor H-related protein family, cutaneous adverse drug, epilepsy, maculopapular exanthema, patients, phenytoin

Datasets

Release 1.2